Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Marquet

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
Therapeutic Drug Monitoring|January 13, 2006
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugsPierre Marquet
Therapeutic Drug Monitoring|March 19, 2002
Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicologyPierre Marquet
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2009
Pretransplantation calcineurin activity: towards individualized therapy?Pierre Marquet
Therapeutic Drug Monitoring|March 28, 2008
Proceedings of the 10th International Congress of Therapeutic Drug Monitoring and Clinical ToxicologyPierre Marquet
Therapeutic Drug Monitoring|January 24, 2002
Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?Pierre Marquet
Clinical Chemistry|March 13, 2010
Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary?Pierre Marquet
Methods in Molecular Biology (Clifton, N.J.)|July 7, 2012
LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assaysPierre Marquet
Therapeutic Drug Monitoring|October 2, 2024
Getting Tacrolimus Dosing RightPierre Marquet
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Cell volume regulation monitored with combined epifluorescence and digital holographic microscopyNicolas Pavillon, Pierre Marquet
Clinical Pharmacokinetics|November 9, 2004
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation periodAnnick Rousseau, Pierre Marquet
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
Therapeutic Drug Monitoring|January 13, 2006
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugsPierre Marquet
Therapeutic Drug Monitoring|March 19, 2002
Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicologyPierre Marquet
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2009
Pretransplantation calcineurin activity: towards individualized therapy?Pierre Marquet
Therapeutic Drug Monitoring|March 28, 2008
Proceedings of the 10th International Congress of Therapeutic Drug Monitoring and Clinical ToxicologyPierre Marquet
Therapeutic Drug Monitoring|January 24, 2002
Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?Pierre Marquet
Clinical Chemistry|March 13, 2010
Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary?Pierre Marquet
Methods in Molecular Biology (Clifton, N.J.)|July 7, 2012
LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assaysPierre Marquet
Therapeutic Drug Monitoring|October 2, 2024
Getting Tacrolimus Dosing RightPierre Marquet
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Cell volume regulation monitored with combined epifluorescence and digital holographic microscopyNicolas Pavillon, Pierre Marquet
Clinical Pharmacokinetics|November 9, 2004
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation periodAnnick Rousseau, Pierre Marquet
Pageof 39